New £180 million Government Support Programme for Innovative Life Science Businesses
The UK Government has announced a new three-year £180 million programme to aid the UK life sciences sector by supporting and driving the development of innovative life sciences products and services. The Biomedical Catalyst fund will provide support, from initial research in universities through to commercial development in small- and medium-sized companies, from incubating innovations in academia to supporting and accelerating companies’ innovative product and process developments. Support will be available to both academically- and commercially-led research and development. The programme will be managed jointly by the Technology Strategy Board and the Medical Research Council.
For more information go to the Technology Strategy Board website.
(source Grants Online, the UK's most comprehensive and up to date funding information service)
